MedTrace Logo

Study of Cerebral Activation by fNIRS During Gait With Different Rhythmic Auditory Stimulations in Healthy Subjects

NCT05789121 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2023-03-31

No results posted yet for this study

Summary

The purpose of this study is to investigate the cerebral activation in healthy subjects in 4 conditions of gait :

* Gait at preferred cadence without auditory stimulation (Gait1)
* Gait with low tempo rhythmic auditory stimulation by music (RAS-Slow). The beat rate of the music was 68.5 per minute for all participants.
* Gait with fast tempo synchronous rhythmic auditory stimulation by music (RAS-Fast). The beat rate of the music was set to 10% above each patient's preferred gait cadence . The preferred cadence was considered as the mean of the 6 trials during Gait 1.
* Gait without auditory stimulation (Gait2) The investigators goal is to compare cerebral activation and gait parameters during the 4 different tasks using fNIRS.

Conditions

  • Healthy

Interventions

DEVICE

walking 25 m in 4 different conditions

The protocol consisted of walking 25 m in 4 different conditions in the following order: Gait1, RAS-Slow, RAS-fast, Gait2. * Gait 1 : preferred cadence without auditory stimulation * RAS-Slow : Gait with low tempo rhythmic auditory stimulation by music (68.5 per minute). * RAS-Fast : Gait with fast tempo (10% above each Gait1 cadence). * Gait2 : preferred cadence without auditory stimulation

Sponsors & Collaborators

  • Centre Hospitalier Régional d'Orléans

    lead OTHER

Principal Investigators

  • Auzou PASCAL, Dr · CHR d'Orleans

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-14
Primary Completion
2023-03-24
Completion
2023-03-24

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05789121 on ClinicalTrials.gov